Sebastian Scholl

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses

Stephan Metzelder, Thomas Schroeder, Anemone Finck et al. · Leukemia · 2012 · 225 citations

Hematological Malignancy, Sustained Responses, Allergy +12

The smaller human VH gene families display remarkably little polymorphism.

I Sanz, Patrick D. Kelly, Carol L. Williams et al. · The EMBO Journal · 1989 · 201 citations · Full text

Allelic Variant, Developmental Biology, Genetic Disorder +5

<i>CEBPA</i> mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

Franziska Taube, Julia Annabell Georgi, Michael Krämer et al. · Blood · 2021 · 159 citations · Full text

Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm—Combined Prospective Analysis by the German AML Intergroup

Thomas Büchner, Richard F. Schlenk, Markus Schaich et al. · Journal of Clinical Oncology · 2012 · 133 citations

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Christoph Röllig, Michael Krämer, Christoph Schliemann et al. · Blood · 2020 · 133 citations · Full text